Zobrazeno 1 - 10
of 120
pro vyhledávání: '"R Camporotondo"'
Autor:
V Dusi, M Ruffinazzi, L Pugliese, F Guerrera, A Vicentini, S Savastano, A Greco, R Camporotondo, S Frea, A Vairo, M Imazio, M Tritto, C Raineri, R Rordorf, G M De Ferrari
Publikováno v:
Europace. 25
Funding Acknowledgements Type of funding sources: None. Background Cardiac Sympathetic Denervation (CSD) has been recently proposed for the treatment of refractory ventricular arrhythmias (VAs) in patients with cardiomyopathy (CMP). A multicentric Am
Autor:
F Renon, B Liccardo, A D'andrea, S Guida, R Totaro, A R Munafo', P Calabro', S Leonardi, R Camporotondo
Publikováno v:
European Heart Journal: Acute Cardiovascular Care. 12
Funding Acknowledgements Type of funding sources: None. Background An update of the Society for Cardiovascular Angiography and Interventions (SCAI) classification of cardiogenic shock has been proposed in 2022, with a refinement of the classification
Autor:
C N J Colombo, V Dammassa, G M Mazza, M Voltini, F Cantarella, L Patrini, E Ambrosini, M Caria, R Camporotondo, F Mojoli, C Pellegrini, G Tavazzi
Publikováno v:
European Heart Journal: Acute Cardiovascular Care. 12
Funding Acknowledgements Type of funding sources: None. Introduction Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a short-term mechanical circulatory support for refractory cardiogenic shock (CS). Successful weaning from VA ECMO is
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
F. Bastaroli, M. Mura, S. Montanaro, F. Misitano, C. Guarona, M.G. Lorusso, L. Pugliese, R. Camporotondo, A. Vicentini, R. Rordorf, M. Gnecchi
Publikováno v:
Cytotherapy. 25:S274-S275
Autor:
C N J Colombo, V Dammassa, L Battistini, M Erba, R Camporotondo, C Pellegrini, F Mojoli, G Tavazzi
Publikováno v:
European Heart Journal. 43
Background Cardiogenic shock (CS) is a life threatening condition due to primary cardiac dysfunction. First line therapy involves drug administration (including inotropes and/or vasopressors) up to mechanical circulatory support. Tachycardia is a com
Autor:
V Dusi, E Baldi, M Ruffinazzi, R Camporotondo, F Angelini, V Peano, C Picollo, A Cipriani, P Cerea, L Cacciavillani, P Noussan, F Dossi, T Sanna, G D'Acunto, M Caputo, A Auricchio, M Kotta, M Gnecchi, L Crotti, P Schwartz, G De Ferrari
Publikováno v:
European Heart Journal Supplements. 25:D1-D1
Introduction Few studies evaluated risk factors for primary ventricular fibrillation (VF) before reperfusion during a first acute myocardial infarction (AMI). Important parameters such as kalemia, blood pressure (BP) and heart rate (HR) at presentati
Autor:
V Dusi, M Ruffinazzi, L Pugliese, F Guerrera, E Baldi, A Sanzo, A Vicentini, S Savastano, A Greco, R Camporotondo, A Vairo, S Frea, A Proclemer, M Driussi, I Massimo, M Tritto, A Trompeo, M Belliato, S Ghio, C Raineri, R Rordorf, G De Ferrari
Publikováno v:
European Heart Journal Supplements. 25:D2-D2
Background Cardiac Sympathetic Denervation (CSD) has been recently proposed for the treatment of refractory ventricular arrhythmias (VAs) in patients with cardiomyopathy (CMP). Long–term outcome and predictors of recurrences after the procedure are
Autor:
M Casula, I Taietti, M Galazzi, I Zeqaj, F Fortuni, S Cornara, A Somaschini, S Leonardi, R Camporotondo, R Totaro, M Ferlini, M Gnecchi
Publikováno v:
European Heart Journal. 42
Background Lipid management plays a key role in secondary prevention after acute coronary syndrome. The 2019 European Society of Cardiology guidelines recommend a more ambitious target than the previous guidelines version (i.e., to achieve LDL choles
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.